The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Mars breaks new ground in heart health with Cocoavia

HACKETTSTOWN, NJ (Sept. 14, 2005) With heart disease remaining the nation's number one killer, Americans increasingly are looking for options to improve their heart health. Now there's a new product hitting store shelves that will allow them to satisfy their passion for chocolate while being good to their heart.

CocoaViaTM is a revolutionary new line of heart-healthy snacks that combines real chocolate pleasure with ingredients formulated to promote a healthy heart. Ingredients in CocoaViaTM can significantly reduce LDL or "bad" cholesterol levels and promote healthy circulation to maintain heart health.

Created after more than a decade of research, CocoaViaTM is the only product that contains a patented blend of heart-healthy cocoa flavanols and cholesterol-lowering plant sterols from soy. The new line of snacks also is fortified with calcium and a mix of heart-healthy nutrients including folic acid, vitamins B-6, B-12, C and E. CocoaViaTM is made by Mars Nutrition for Health & Well-Being, a new division of Mars, Incorporated, makers of some of the world's best-loved, great-tasting chocolate brands. "CocoaViaTM is the vanguard of our efforts to 'reinvent' cocoa as an ingredient in healthful foods," said Dr. Harold Schmitz, chief science officer at Mars. "It's a first-of-its-kind product that was purposely designed to deliver heart-health benefits and real chocolate pleasure in products that are less than 150 calories per serving."

Mars first introduced CocoaViaTM granola-based snack bars nearly two years ago and sold the product exclusively on the Internet. Now a full line of CocoaViaTM products including new chocolate bars (original, crispy and blueberry & almond) and chocolate-covered almonds will be available at retail beginning in October. Pre-orders can be made online at www.cocoavia.com until the product reaches nat
'"/>

Contact: Rachel McMahon
rmcmahon@webershandwick.com
312-988-2462
Weber Shandwick Worldwide
19-Sep-2005


Page: 1 2 3 4 5

Related medicine news :

1. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
2. Shift in feeding behavior of mosquitoes sheds light on West Nile virus outbreaks
3. UCI joins international effort to model influenza outbreaks
4. Sequence-based early warning system for the detection of MRSA outbreaks in hospitals
5. Regional governments may be reluctant to report outbreaks
6. Pandemic planning: Regional governments may be reluctant to report outbreaks
7. New tools used to control foodborne hepatitis A outbreaks related to green onions
8. National Academies Advisory -- June 8 public briefing on LANL groundwater protection
9. RAND study finds school playgrounds can help fight childhood obesity
10. Columbia U receives $16.9M award to study origin and health effects of arsenic in ground water
11. Novel therapy combinations gain ground in treating hepatitis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mars breaks new ground heart health with Cocoavia

(Date:11/24/2009)... The molecular cause of inflammatory bowel disease...d at the upcoming 2009 Advances in Inflammatory Bo...dation’s Clinical & Research Conference,...tify a causative mutation for Crohn’s diseas... November 24, 2009 -- The molecular cause of infla...
(Date:11/24/2009)...24/PRNewswire/--NIP,Inc.todayannouncedtheacquisiti...leadingexecutivecompensationandbenefitplanprovider...fficesinLosAngeles,Milwaukee,Boston,ChicagoandAtla...dexpertintheexecutivebenefitsindustry. ,, "Wear...assignificantmarketpresence,"statesBillPollock,Cha...
(Date:11/24/2009)...if.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcare...lpingHispanic-Americanseniorsunderstandthebasicsof...otakeafreeZumba®Goldclass,aLatin-infusedfitne...ia,rumba,andtango. ,, UnitedHealthcarewilloffer...eandengagedwhenlearningabouttheirhealthcareoptions...
(Date:11/24/2009).../PRNewswire/--TheUnionLaborLifeInsuranceCompany("U...SP(®),()thenation,slargestvisionbenefitsandse...uctstounions,uniontrustfunds,unionemployersandthei...ringservicesincludingcomprehensiveeyeexams,broadse...ortantqualityeyecareis,"statedBruceSmith,NationalS...
(Date:11/24/2009)... may help ward off peripheral artery disease, res...hDay News) -- Among people aged 75 and older, the ...eart attacks, stroke or death, a new study finds. ...l remedy might help prevent the leg-circulation pr... , Ginkgo contains nutrients called flavonoids,...
Breaking Medicine News(10 mins):Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
(Date:11/24/2009)...IFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- Eisai...ugAdministration(FDA)hasacceptedforreviewEisai,sNe...(donepezilHClextendedrelease)tabletsforthetreatmen...igherdoseformulationcontains23mgofdonepezilHClinan...emthatallowsforgradualreleaseofthedrug.TheNDAisbas...
(Date:11/24/2009)...H,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstitute...thepharmaceuticalandbiotechindustry,todayannounced... .Thenew HospitalMarketplace e-courseisthenewestad...series,acomprehensiveseriesofe-coursesdesignedtofi...knowledgeforcommercialprofessionals. ,, Thenewt...
(Date:11/24/2009)...SAUGA,Ontario,Nov.24/PRNewswire-FirstCall/--Cardio...eroftechnologyandproductstargetingtheimmunoassayse....A.S.("MerckChimie")isprogressingtothenextphaseoft...rcoatedparamagneticBeads("Beads"). ,, Pertheagr...r,CardioGenicssuppliedMerckChimiewithitsproprietar...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3MedAssurant to Support AHIPs Research Capabilities 57024 1MedAssurant to Support AHIPs Research Capabilities 57024 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3Chlorine in Pools Raises Kids Asthma Allergy Risk 57019 1Chlorine in Pools Raises Kids Asthma Allergy Risk 57019 2Chlorine in Pools Raises Kids Asthma Allergy Risk 57019 3
Other News:
...ons cause neurodegenerative diseases in humans and... humans or animals get sick sporadically, when, fo...lled PrPc change to harmful prions (called PrPSc).... of the brain that kills the victims within a matt...
...tors have long known that smokers rarely suffer fr...D) called ulcerative colitis, but they didn't know... Journal of Experimental Medicine might help expla...colleagues at the University of Pittsburgh now sho...
...ng adults with amblyopia, or lazy eye, can improve...treatment developed by researchers at USC and thre...n appears normal but does not see properly, even w...not develop fully, resulting in permanent loss of ...
...TREAL, December 20, 2005--Researchers have discove...ich reduce gastric acidity, are potential risk fac...f hospitals. The new research to be published in t...MA) tomorrow focuses on community-acquired C. diff...
health news:Carbon monoxide soothes inflammatory bowel disease 2health news:Adults with lazy eye can improve 2health news:Heart burn medication a risk factor for community-acquired C. difficile 2
... the National Patient Safety Foundation (NPSF).wil...nd build consensus around a.collaborative action p...n.leaders will participate, representing five key ...e FDA & Government, Medicine & Health Care Practit...
.In predicting violent behavior among teenagers, cliques and high school social.sets do matter, finds a new, large-scale study, the first to examine this factor.in a systematic manner. So does marijua
...ygrounds through partnership between health servic...dy).One way of improving safety in children's play...es to form a partnership in the surveillance of in...s, say researchers from Cardiff. Writing in this ...
...nts with refractory chronic lymphocytic.leukemia.D...une 12 ---ILEXTM Oncology, Inc. (NASDAQ: ILXO) and...nal results from an international,.multi-center, p... treatment of patients with B-cell.chronic lymphoc...
health news:NPSF workshop builds community to improve pharmaceutical safety 2health news:Study finds predictors for youth violence and drugs 2health news:Study finds predictors for youth violence and drugs 3health news:Study finds predictors for youth violence and drugs 4health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 2health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 3health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 4health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 5